Chris Naprawa

Chris Naprawa is a declared insider of Khiron Life Sciences Corp., with filings sourced from SEDI. Over a trading history stretching from 26 June 2018 to 10 June 2022, the count stands at 18 filings.

Every open-market trade on record is a purchase: 11 purchases worth €158k, and no sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 2 option exercises.

The median purchase comes to €11k. None of the 9 purchases we analysed coincided with buying by another insider of the same company within 30 days.

On 14 June 2022 came the latest disclosure, a transaction for €111k in Khiron Life Sciences Corp. The last insider purchase was made public on 23 December 2021, 1,766 days ago. Between a trade and the moment it shows up on SEDI, the median delay is 4 days. The shorter that gap, the sooner other investors can see what insiders have done. This summary is built from SEDI disclosures alone and does not predict where the share price will go.